It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

Less than 48 hours after their season came to an end, the Lions lost again. On Monday, Ben Johnson decided to leave his post as Detroit's offensive coordinator. He will reportedly stay in the NFC ...

In an alternate universe, Ben Johnson could be coaching against the Detroit Lions this week in the NFC playoffs. Johnson was widely considered the frontrunner for the Washington Commanders vacant ...

You can find her at X @LMeeMotorsport. NASCAR legend Jimmie Johnson has found himself at the center of attention as he prepares to compete in the upcoming Daytona 500, with added pressure stemming ...

One prospect you haven't heard as much about lately is second baseman Termarr Johnson, who has seen his prospect star fade recently. According to MLB Pipeline, Johnson was the No. 26 prospect in ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Rep. Thomas Massie, one of the most outspoken critics of House Speaker Mike Johnson, is off the powerful House Rules Committee, which plays a critical role in the functioning of the lower chamber ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

The purchase will allow Johnson & Johnson to delve further into the treatment of central nervous system disorders. The purchase is one of several transactions in recent years to boost its ...

NEW BRUNSWICK, N.J. and BEDMINSTER, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced ...